Back to Treatments

Treatment

Alectinib

1
Conditions
200
Trials
15K
Participants
32%
Average Safety

Condition Evidence

Tracheal, bronchus, and lung cancer

200 trials · 15K participants

88% effectiveness · 32% safety
Alectinib | DFDA